Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Dawood Sayed

Pain Medicine Kansas City, KS Medical Doctor

NPI 1194942219 CMS profile 8578

University Of Kansas Medical Center 3901 Blvd, Ms 1034, Kansas City, KS 66160

Open in the dashboard

General payments

$649,470

759 records reported · program years 2019–2025

Research payments

$72,963

Paid to them · 12 records reported · program years 2019–2025

Ownership & investment interest

$56,490

7 holdings reported · through program year 2025

Research they led as principal investigator

$1,026,740 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Dawood Sayed of Kansas City, KS is reported in the CMS Open Payments database as having received $649,470 across 759 general payments and $72,963 in research payments paid to them. Separately, studies naming them as principal investigator received $1,026,740 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $56,490 across 7 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

16 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $33,790 78
2024 General $35,545 55
2023 General $112,044 94
2022 General $98,071 119
2022 Research $1,250 1
2021 General $107,365 103
2021 Research $71,713 11
2020 General $89,940 90
2019 General $172,714 220
2025 Ownership $8,070 1
2024 Ownership $8,070 1
2023 Ownership $8,070 1
2022 Ownership $8,070 1
2021 Ownership $8,070 1
2020 Ownership $8,070 1
2019 Ownership $8,070 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Dawood Sayed
  • Pain Medicine median
  • Middle half of Pain Medicine
  • National median

In program year 2025, general payments to Dawood Sayed were reported at $33,790. Among 2,779 Pain Medicine profiles paid that year, the median was $458 and the middle half received between $124 and $1,401.

Show as a table
Year Dawood Sayed Pain Medicine median Middle half National median
2019 $172,714 $498 $126–$1,682 $163
2020 $89,940 $284 $80–$910 $114
2021 $107,365 $399 $112–$1,219 $132
2022 $98,071 $455 $137–$1,484 $149
2023 $112,044 $484 $128–$1,495 $160
2024 $35,545 $498 $131–$1,540 $164
2025 $33,790 $458 $124–$1,401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Nevro Corp. $186,659 305 payments
  2. Saluda Medical Americas, Inc. $149,512 81 payments
  3. Painteq LLC $81,041 116 payments
  4. Abbott Laboratories $55,509 90 payments
  5. Vertos Medical, Inc. $42,059 18 payments
  6. Vertiflex, Inc. $31,599 27 payments
  7. Medtronic USA, Inc. $29,101 26 payments
  8. MML US, Inc. $23,577 23 payments
  9. SurGenTec $20,684 5 payments
  10. Flowonix Medical Incorporated $19,684 2 payments
  11. Other $10,046 66 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $344,630 145 payments
  2. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $86,888 18 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $84,063 20 payments
  4. Compensation for serving as faculty or as a speaker for a medical education program $36,553 23 payments
  5. Food and Beverage $34,569 475 payments
  6. Travel and Lodging $27,471 71 payments
  7. Education $23,100 4 payments
  8. Current or prospective ownership or investment interest $12,133 2 payments
  9. Entertainment $64 1 payment
Products named General payments · program years 2019–2025
  1. Senza Spinal Cord Stimulation System $137,971 216 payments
  2. Evoke SCS $131,052 56 payments
  3. PAINTEQ $81,041 116 payments
  4. Omnia $48,021 78 payments
  5. mild Device Kit $36,442 13 payments
  6. Superion ISS $31,599 27 payments
  7. ReActiv8 $23,577 23 payments
  8. PROCLAIM $20,286 23 payments
  9. Prometra II $19,684 2 payments
  10. Evoke $18,460 25 payments
  11. Other $96,125 175 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Painteq LLC $55,287 4 payments
  2. Saluda Medical Americas, Inc. $16,476 7 payments
  3. Nevro Corp. $1,200 1 payment

Billing to Medicare

Part B · data year 2024 · 77 billing codes

Paid by Medicare

$219,739

Medicare's payments for the services billed

Medicare patients

582

Average age 73

Services billed

2,345

319 women, 263 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 71%
Ischemic heart disease 36%
Depression 35%
Diabetes 28%
Chronic kidney disease 24%
Osteoporosis 24%
Cancer 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

771 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pain Medicine in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record